← Back to PeopleSKExecutiveSamarth KulkarniChief Executive Officer at CRISPR TherapeuticsLinkedInDr. Samarth Kulkarni serves as Chief Executive Officer of CRISPR Therapeutics.1Mentions1Articles1OutletsCompanies CoveredAkeso1AstraZeneca1Eli Lilly1Innovent1Roche1Summit Therapeutics1Wuxi Biologics1ArticlesMost recent firstMentioned InReferenced in coverageClinical Trials Are Increasingly Going Global With China a Main BeneficiaryBioSpacemixedJun 7, 2026“Announced CRISPR Therapeutics is testing an allogeneic CAR T in India because the region needs more affordable medical options.”